tradingkey.logo

Rapid Micro Biosystems Inc

RPID
2.750USD
-0.120-4.18%
Close 11/06, 16:00ETQuotes delayed by 15 min
121.16MMarket Cap
LossP/E TTM

Rapid Micro Biosystems Inc

2.750
-0.120-4.18%

More Details of Rapid Micro Biosystems Inc Company

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

Rapid Micro Biosystems Inc Info

Ticker SymbolRPID
Company nameRapid Micro Biosystems Inc
IPO dateJul 15, 2021
CEOMr. Robert (Rob) Spignesi
Number of employees163
Security typeOrdinary Share
Fiscal year-endJul 15
Address25 Hartwell Avenue
CityLEXINGTON
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code02421
Phone19783493200
Websitehttps://www.rapidmicrobio.com/
Ticker SymbolRPID
IPO dateJul 15, 2021
CEOMr. Robert (Rob) Spignesi

Company Executives of Rapid Micro Biosystems Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+14.79%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+58.85%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
28.60K
+100.00%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Sean M. Wirtjes, CPA
Mr. Sean M. Wirtjes, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. John Wilson
Mr. John Wilson
Chief Operating Officer
Chief Operating Officer
--
--
Mr. James Xu
Mr. James Xu
Senior Vice President - Legal, Company Secretary
Senior Vice President - Legal, Company Secretary
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Richard S. Kollender
Mr. Richard S. Kollender
Independent Director
Independent Director
111.02K
+14.79%
Ms. Inese Lowenstein
Ms. Inese Lowenstein
Independent Director
Independent Director
38.60K
+58.85%
Mr. Natale S. (Nat) Ricciardi
Mr. Natale S. (Nat) Ricciardi
Independent Director
Independent Director
28.60K
+100.00%
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Dr. Kirk D. Malloy, Ph.D.
Dr. Kirk D. Malloy, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert (Rob) Spignesi
Mr. Robert (Rob) Spignesi
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Product revenue
4.42M
60.85%
Service revenue
2.84M
39.15%
By RegionUSD
Name
Revenue
Proportion
United States
2.36M
32.54%
Germany
2.00M
27.61%
Switzerland
1.64M
22.54%
All other countries
961.00K
13.23%
Japan
296.00K
4.08%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product revenue
4.42M
60.85%
Service revenue
2.84M
39.15%

Shareholding Stats

Updated: Fri, Aug 15
Updated: Fri, Aug 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Bain Capital Life Sciences Investors, LLC
21.24%
Kennedy Lewis Investment Management LLC
12.44%
Longitude Capital Management Co., LLC
8.96%
Endeavour Medtech Growth II LP
5.68%
Ally Bridge Group (HK) Limited
4.65%
Other
47.02%
Shareholders
Shareholders
Proportion
Bain Capital Life Sciences Investors, LLC
21.24%
Kennedy Lewis Investment Management LLC
12.44%
Longitude Capital Management Co., LLC
8.96%
Endeavour Medtech Growth II LP
5.68%
Ally Bridge Group (HK) Limited
4.65%
Other
47.02%
Shareholder Types
Shareholders
Proportion
Investment Advisor
36.80%
Venture Capital
9.06%
Investment Advisor/Hedge Fund
6.98%
Corporation
5.68%
Hedge Fund
5.25%
Individual Investor
4.22%
Private Equity
1.46%
Research Firm
0.04%
Other
30.51%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
56
23.66M
59.58%
-1.57M
2025Q2
68
28.04M
71.29%
+1.90M
2025Q1
76
27.59M
71.01%
+589.97K
2024Q4
81
24.48M
63.27%
-5.50M
2024Q3
105
26.74M
70.33%
-7.92M
2024Q2
116
27.58M
73.05%
-8.07M
2024Q1
141
28.00M
74.27%
-11.17M
2023Q4
153
28.87M
77.88%
-11.80M
2023Q3
163
30.20M
81.80%
-11.32M
2023Q2
163
30.56M
83.28%
-10.69M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Bain Capital Life Sciences Investors, LLC
8.43M
21.24%
--
--
Jun 30, 2025
Kennedy Lewis Investment Management LLC
4.94M
12.44%
--
--
Sep 30, 2024
Longitude Capital Management Co., LLC
3.56M
8.96%
--
--
Apr 07, 2025
Endeavour Medtech Growth II LP
2.26M
5.68%
--
--
Apr 07, 2025
Ally Bridge Group (HK) Limited
1.85M
4.65%
--
--
Jun 30, 2025
Schonfeld Strategic Advisors LLC
1.04M
2.61%
+8.86K
+0.86%
Jun 30, 2025
Parkman Healthcare Partners LLC
913.44K
2.3%
+177.82K
+24.17%
Jun 30, 2025
The Vanguard Group, Inc.
904.36K
2.28%
+14.09K
+1.58%
Jun 30, 2025
Advent International L.P.
577.78K
1.46%
--
--
Jun 30, 2025
Spignesi (Robert G JR)
493.93K
1.24%
-378.44K
-43.38%
Jul 14, 2025
View more

Related ETFs

Updated: 15 hours ago
Updated: 15 hours ago
Name
Proportion
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Proportion0.02%
Dimensional US Core Equity 1 ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI